QUINCE THERAPEUTICS INC (QNCX)

US22053A1079 - Common Stock

1.99  +0.04 (+2.05%)

After market: 2 +0.01 (+0.5%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
38.06M28.72M51.19M90.32M78.89M
Research and Development
19.50M9.45M25.18M60.80M61.31M
Selling, General, and Administrative Expenses
14.90M17.70M26.01M29.52M17.59M
Operating Income
-38.06M-28.72M-51.19M-90.32M-78.89M
Interest Income/Expense
3.41M3.48M1.07M620.00K2.04M
Other Income/Expense
-1.35M-374.00K-1.00M-250.00KN/A
Non Recurring Items
-17.13M-5.97M-830.00KN/AN/A
Income Before Taxes
-53.13M-31.58M-51.94M-89.95M-76.85M
Income Tax
131.00K-197.00K-280.00KN/AN/A
Net Income
-53.26M-31.39M-51.66M-89.95M-76.85M
EBITDA
-37.59M-28.40M-50.99M-89.98M-78.56M
 
Per Share Data
EPS Diluted Total Ops
-1.25-0.84-1.54-3.03-2.63
Non GAAP EPS
N/AN/AN/A-3.03-2.63
 
Statistics

All data in USD

Charts